Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1975 Jun 7;112(11):1301–1309.

Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.

H Guyda, H Friesen, J D Bailey, G Leboeuf, J C Beck
PMCID: PMC1956139  PMID: 165002

Abstract

The Medical Research Council of Canada has initiated human growth hormone (hGH) therapy in 151 patients with documented complete hGH deficiency that was idiopathic in 76% of cases, secondary to craniopharyngioma (organic) in 17% and of varied cause in 7%. Approximately 50% of the patients with idiopathic disease had isolated hGH deficiency; during therapy thyroid deficiency developed in five patients and cortisol deficiency in three. A similar increase in mean height velocity occurred in the first treatment phase for patients less than 12 years old (0.93 plus or minus 0.30 cm/mo) and those 12 years and older (0.86 plus or minus 0.29 cm/mo). Although subsequent courses of hGH therapy yielded significantly diminished response in both age groups, this diminution was not progressive: the height velocity of the younger patients returned to 0.82 plus or minus 0.26 cm/ml in the fifth therapy phase. The mean height velocity attained at the optimal dosage (0.20 to 0.29 units/kg three times per week) for each age group did not differ significantly. Despite therapy being carried out for only 6 months of the year, normal increment ratios for height age and bone age against chronologic age were observed in the patients with idiopathic disease. In only four patients did treatment failure occur, and three of these were more than 20 years old. The addition of fluoxymesterone (10 mg/d) to the hGH therapeutic regimen (15 units/wk), when diminished response to hGH alone became evident, promoted an enhanced growth response in 9 of 11 older patients. These data indicate that age of the patient and dosage of hGH, but not diagnostic category, were important influences on the response to therapy. Younger patients responded best and maintained a higher mean growth velocity than older patients during intermittent hGH therapy

Full text

PDF
1301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aceto T., Jr, Frasier S. D., Hayles A. B., Meyer-Bahlburg H. F., Parker M. L., Munschauer R., Di Chiro G. Collaborative study of the effects of human growth hormone in growth hormone deficiency. I. First year of therapy. J Clin Endocrinol Metab. 1972 Oct;35(4):483–496. doi: 10.1210/jcem-35-4-483. [DOI] [PubMed] [Google Scholar]
  2. BRASEL J. A., WRIGHT J. C., WILKINS L., BLIZZARD R. M. AN EVALUATION OF SEVENTY-FIVE PATIENTS WITH HYPOPITUITARISM BEGINNING IN CHILDHOOD. Am J Med. 1965 Apr;38:484–498. doi: 10.1016/0002-9343(65)90127-0. [DOI] [PubMed] [Google Scholar]
  3. Deller J. J., Jr, Boulis M. W., Harriss W. E., Hutsell T. C., Garcia J. F., Linfoot J. A. Growth hormone response patterns to sex hormone administration in growth retardation. Am J Med Sci. 1970 Apr;259(4):292–297. doi: 10.1097/00000441-197004000-00007. [DOI] [PubMed] [Google Scholar]
  4. Frasier S. D. A preview of growth hormone stimulation tests in children. Pediatrics. 1974 Jun;53(6):929–937. [PubMed] [Google Scholar]
  5. Frasier S. D., Smith F. G., Jr Antibodies to human growth hormone. Development during therapy with human growth hormone. Am J Dis Child. 1966 Nov;112(5):383–388. doi: 10.1001/archpedi.1966.02090140055001. [DOI] [PubMed] [Google Scholar]
  6. Friesen H., Guyda H., Hardy J. The biosynthesis of human growth hormone and prolactin. J Clin Endocrinol Metab. 1970 Dec;31(6):611–624. doi: 10.1210/jcem-31-6-611. [DOI] [PubMed] [Google Scholar]
  7. Grunt J. A., Enriquez A. R. Acute and long-term responsiveness to growth hormone in children with short stature. Pediatr Res. 1972 Aug;6(8):664–674. doi: 10.1203/00006450-197208000-00004. [DOI] [PubMed] [Google Scholar]
  8. Henneman P. H. The effect of human growth hormone on growth of patients with hypopituitarism. A combined study. JAMA. 1968 Sep 16;205(12):828–836. [PubMed] [Google Scholar]
  9. Illig R., Prader A. Effect of testosterone on growth hormone secretion in patients with anorchia and delayed puberty. J Clin Endocrinol Metab. 1970 May;30(5):615–618. doi: 10.1210/jcem-30-5-615. [DOI] [PubMed] [Google Scholar]
  10. Kaplan S. L., Abrams C. A., Bell J. J., Conte F. A., Grumbach M. M. Growth and growth hormone. I. Changes in serum level of growth hormone following hypoglycemia in 134 children with growth retardation. Pediatr Res. 1968 Jan;2(1):43–63. doi: 10.1203/00006450-196801000-00005. [DOI] [PubMed] [Google Scholar]
  11. Keenan B. S., Beitins I. Z., Lee P. A., Kowarski A., Blizzard R. M., Migeon C. J. Estimation of ACTH reserve on normal and hypopituitary subjects: comparison of oral and intravenous metyrapone with insulin hypoglycemia. J Clin Endocrinol Metab. 1973 Oct;37(4):540–549. doi: 10.1210/jcem-37-4-540. [DOI] [PubMed] [Google Scholar]
  12. Kenny F. M., Guyda H. J., Wright J. C., Friesen H. G. Prolactin and somatomedin in hypopituitary patients with "catch up" growth following operations for craniopharyngioma. J Clin Endocrinol Metab. 1973 Feb;36(2):378–380. doi: 10.1210/jcem-36-2-378. [DOI] [PubMed] [Google Scholar]
  13. Kirkland R. T., Kirkland J. L., Librik L., Clayton G. W. Results of intermittent human growth hormone (HGH) therapy in hypopituitary dwarfism. J Clin Endocrinol Metab. 1973 Aug;37(2):204–211. doi: 10.1210/jcem-37-2-204. [DOI] [PubMed] [Google Scholar]
  14. Kulin H. E., Reiter E. O. Gonadotropins during childhood and adolescence: a review. Pediatrics. 1973 Feb;51(2):260–271. [PubMed] [Google Scholar]
  15. MacGillivray M. H., Kolotkin M., Munschauer R. W. Enhanced linear growth responses in hypopituitary dwarfs treated with growth hormone plus androgen versus growth hormone alone. Pediatr Res. 1974 Feb;8(2):103–108. doi: 10.1203/00006450-197402000-00006. [DOI] [PubMed] [Google Scholar]
  16. Marshall W. A., Tanner J. M. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969 Jun;44(235):291–303. doi: 10.1136/adc.44.235.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Martin L. G., Clark J. W., Connor T. B. Growth hormone secretion enhanced by androgens. J Clin Endocrinol Metab. 1968 Mar;28(3):425–428. doi: 10.1210/jcem-28-3-425. [DOI] [PubMed] [Google Scholar]
  18. PARKER M. L., MARIZ I. K., DAUGHADAY W. H. RESISTANCE TO HUMAN GROWTH HORMONE IN PITUITARY DWARFISM: CLINICAL AND IMMUNOLOGIC STUDIES. J Clin Endocrinol Metab. 1964 Oct;24:997–1004. doi: 10.1210/jcem-24-10-997. [DOI] [PubMed] [Google Scholar]
  19. PRADER A., WAGNER H., SZEKY J., ILLIG R., TOUBER J. L., MAINGAY D. ACQUIRED RESISTANCE TO HUMAN GROWTH HORMONE CAUSED BY SPECIFIC ANTIBODIES. Lancet. 1964 Aug 22;2(7356):378–382. doi: 10.1016/s0140-6736(64)90390-3. [DOI] [PubMed] [Google Scholar]
  20. Penny R., Blizzard R. M. The possible influence of puberty on the release of growth hormone in three males with apparent isolated growth hormone deficiency. J Clin Endocrinol Metab. 1972 Jan;34(1):82–84. doi: 10.1210/jcem-34-1-82. [DOI] [PubMed] [Google Scholar]
  21. Prader A., Zachmann M., Poley J. R., Illig R., Széky J. Long-term treatment with human growth hormone (Raben) in small doses. Evaluation of 18 hypopituitary patients. Helv Paediatr Acta. 1967 Oct;22(5):423–440. [PubMed] [Google Scholar]
  22. ROTH J., GLICK S. M., YALOW R. S., BERSON S. A. ANTIBODIES TO HUMAN GROWTH HORMONE (HGH) IN HUMAN SUBJECTS TREATED WITH HGH. J Clin Invest. 1964 Jun;43:1056–1065. doi: 10.1172/JCI104989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Root A. W., Bongiovanni A. M., Eberlein W. R. Diagnosis and management of growth retardation with special reference to the problem of hypopituitarism. J Pediatr. 1971 May;78(5):737–753. doi: 10.1016/s0022-3476(71)80344-x. [DOI] [PubMed] [Google Scholar]
  24. Tanner J. M., Whitehouse R. H., Hughes P. C., Vince F. P. Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints. Arch Dis Child. 1971 Dec;46(250):745–782. doi: 10.1136/adc.46.250.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. WRIGHT J. C., BRASEL J. A., ACETO T., Jr, FINKELSTEIN J. W., KENNY F. M., SPAULDING J. S., BLIZZARD R. M. STUDIES WITH HUMAN GROWTH HORMONE (HGH). Am J Med. 1965 Apr;38:499–516. doi: 10.1016/0002-9343(65)90128-2. [DOI] [PubMed] [Google Scholar]
  26. Winter J. S., De Groot G. W., Faiman C. Idiopathic sexual precocity in a boy with growth hormone, prolactin and thyrotropin deficiencies. J Clin Endocrinol Metab. 1974 Aug;39(2):356–363. doi: 10.1210/jcem-39-2-356. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES